Project Details
| Status | Active |
|---|---|
| Effective start/end date | 5/16/19 → 8/31/50 |
Funding
- Ovid Therapeutics Inc.
TAK -935-001-OLE: A PHASE 2, PROSPECTIVE, INTERVENTIONAL, OPEN-LABEL, MULTI-SITE, EXTENSION STUDY TO ASSESS THE LONG-TERM SAFETY AND TOLERABILITY OF TAK-935 AS ADJUNCTIVE THERAPY IN PATIENTS WITH RARE EPILEPSY
- Laux, Linda C (PD/PI)
- Millichap, John J (PD/PI)
Project: Research project